GB1240545A - Silver-containing therapeutic agents - Google Patents
Silver-containing therapeutic agentsInfo
- Publication number
- GB1240545A GB1240545A GB33831/68A GB3383168A GB1240545A GB 1240545 A GB1240545 A GB 1240545A GB 33831/68 A GB33831/68 A GB 33831/68A GB 3383168 A GB3383168 A GB 3383168A GB 1240545 A GB1240545 A GB 1240545A
- Authority
- GB
- United Kingdom
- Prior art keywords
- silver
- july
- carrier
- sulphadiazine
- therapeutic agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229910052709 silver Inorganic materials 0.000 title abstract 11
- 239000004332 silver Substances 0.000 title abstract 11
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 title abstract 10
- 239000003814 drug Substances 0.000 title 1
- 229940124597 therapeutic agent Drugs 0.000 title 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 2
- 239000002674 ointment Substances 0.000 abstract 2
- UEJSSZHHYBHCEL-UHFFFAOYSA-N silver(1+) sulfadiazinate Chemical compound [Ag+].C1=CC(N)=CC=C1S(=O)(=O)[N-]C1=NC=CC=N1 UEJSSZHHYBHCEL-UHFFFAOYSA-N 0.000 abstract 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract 1
- 229930182555 Penicillin Natural products 0.000 abstract 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 abstract 1
- 239000004098 Tetracycline Substances 0.000 abstract 1
- RRDRHWJDBOGQHN-JWCTVYNTSA-N [2-[(2s,5r,8s,11s,14r,17s,22s)-17-[(1r)-1-hydroxyethyl]-22-[[(2s)-2-[[(2s,3r)-3-hydroxy-2-[[(2s)-2-[6-methyloctanoyl(sulfomethyl)amino]-4-(sulfomethylamino)butanoyl]amino]butyl]amino]-4-(sulfomethylamino)butanoyl]amino]-5,8-bis(2-methylpropyl)-3,6,9,12,15 Chemical compound CCC(C)CCCCC(=O)N(CS(O)(=O)=O)[C@@H](CCNCS(O)(=O)=O)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCNCS(O)(=O)=O)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](CCNCS(O)(=O)=O)NC(=O)[C@H](CCNCS(O)(=O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCNCS(O)(=O)=O)NC1=O RRDRHWJDBOGQHN-JWCTVYNTSA-N 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- XIURVHNZVLADCM-IUODEOHRSA-N cefalotin Chemical compound N([C@H]1[C@@H]2N(C1=O)C(=C(CS2)COC(=O)C)C(O)=O)C(=O)CC1=CC=CS1 XIURVHNZVLADCM-IUODEOHRSA-N 0.000 abstract 1
- 229960000603 cefalotin Drugs 0.000 abstract 1
- 229940108538 colistimethate Drugs 0.000 abstract 1
- 108700028201 colistinmethanesulfonic acid Proteins 0.000 abstract 1
- 239000008311 hydrophilic ointment Substances 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 239000007764 o/w emulsion Substances 0.000 abstract 1
- 229940049954 penicillin Drugs 0.000 abstract 1
- NBYLLBXLDOPANK-UHFFFAOYSA-M silver 2-carboxyphenolate hydrate Chemical compound C1=CC=C(C(=C1)C(=O)O)[O-].O.[Ag+] NBYLLBXLDOPANK-UHFFFAOYSA-M 0.000 abstract 1
- -1 silver tetracycline Chemical class 0.000 abstract 1
- 239000011780 sodium chloride Substances 0.000 abstract 1
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 abstract 1
- QPPBRPIAZZHUNT-UHFFFAOYSA-N sulfamerazine Chemical compound CC1=CC=NC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 QPPBRPIAZZHUNT-UHFFFAOYSA-N 0.000 abstract 1
- 229960002597 sulfamerazine Drugs 0.000 abstract 1
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 abstract 1
- 229960002211 sulfapyridine Drugs 0.000 abstract 1
- GECHUMIMRBOMGK-UHFFFAOYSA-N sulfapyridine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=CC=CC=N1 GECHUMIMRBOMGK-UHFFFAOYSA-N 0.000 abstract 1
- JNMRHUJNCSQMMB-UHFFFAOYSA-N sulfathiazole Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CS1 JNMRHUJNCSQMMB-UHFFFAOYSA-N 0.000 abstract 1
- 229960001544 sulfathiazole Drugs 0.000 abstract 1
- 229940124530 sulfonamide Drugs 0.000 abstract 1
- 229960002180 tetracycline Drugs 0.000 abstract 1
- 229930101283 tetracycline Natural products 0.000 abstract 1
- 235000019364 tetracycline Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/38—Silver; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65383067A | 1967-07-17 | 1967-07-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1240545A true GB1240545A (en) | 1971-07-28 |
Family
ID=24622450
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB33831/68A Expired GB1240545A (en) | 1967-07-17 | 1968-07-16 | Silver-containing therapeutic agents |
| GB4945970A Expired GB1240546A (en) | 1967-07-17 | 1968-07-16 | Improvements in or relating to antibacterial compounds |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB4945970A Expired GB1240546A (en) | 1967-07-17 | 1968-07-16 | Improvements in or relating to antibacterial compounds |
Country Status (8)
| Country | Link |
|---|---|
| BE (1) | BE718183A (enrdf_load_stackoverflow) |
| DE (1) | DE1792053B1 (enrdf_load_stackoverflow) |
| ES (1) | ES356142A1 (enrdf_load_stackoverflow) |
| FR (2) | FR1586125A (enrdf_load_stackoverflow) |
| GB (2) | GB1240545A (enrdf_load_stackoverflow) |
| IE (1) | IE32197B1 (enrdf_load_stackoverflow) |
| NL (1) | NL6809794A (enrdf_load_stackoverflow) |
| PH (1) | PH10639A (enrdf_load_stackoverflow) |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992004029A1 (en) * | 1990-08-29 | 1992-03-19 | Donald Leslie Simmons | Composition containing silver sulfadiazine and benzocaine for use in the treatment of wounds following laser surgery |
| EP0480189A1 (en) * | 1990-10-05 | 1992-04-15 | Altergon S.A. | Pharmaceutical compositions for topical use comprising hyaluronic acid sodium salt and disinfectant substances |
| EP0291159A3 (en) * | 1987-04-01 | 1993-03-17 | Dak-Laboratoriet A/S | Aminosalicylic-acid derivatives for the treatment of psoriasis |
| WO2004103980A1 (en) * | 2003-05-21 | 2004-12-02 | Biovitrum Ab | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type i |
| WO2004112784A1 (en) * | 2003-06-25 | 2004-12-29 | Biovitrum Ab | New use i |
| WO2004113310A1 (en) * | 2003-06-25 | 2004-12-29 | Biovitrum Ab | Use of an inhibitor of 11-b-hydroxysteroid dehydrogenase type 1 compounds for promoting wound healing |
| WO2004112783A1 (en) * | 2003-06-25 | 2004-12-29 | Biovitrum Ab | New use iv |
| WO2004112785A1 (en) * | 2003-06-25 | 2004-12-29 | Biovitrum Ab | New use iii |
| WO2004112779A1 (en) * | 2003-06-25 | 2004-12-29 | Biovitrum Ab | New use vii |
| WO2004112782A1 (en) * | 2003-06-25 | 2004-12-29 | Biovitrum Ab | New use v |
| US7074788B2 (en) | 2001-11-22 | 2006-07-11 | Biovitrum Ab | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| US7173030B2 (en) | 2003-05-21 | 2007-02-06 | Biovitrum Ab | Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1 |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4049802A (en) | 1975-03-19 | 1977-09-20 | Research Corporation | Zinc sulfadiazine and its use in the treatment of burns |
| DE2804931A1 (de) * | 1978-02-06 | 1979-08-16 | Fresenius Chem Pharm Ind | Metallsulfadiazine in feinteiliger form |
| US4384117A (en) * | 1980-03-18 | 1983-05-17 | The United States Of America As Represented By The Secretary Of The Army | Silver metachloridine |
| BRPI1104620B1 (pt) * | 2011-09-09 | 2020-04-07 | Lucia Teixeira De Carvalho | composição farmacêutica para tratamento de queimaduras e lesões da pele e seu processo de preparação |
-
1968
- 1968-07-05 PH PH9358A patent/PH10639A/en unknown
- 1968-07-10 NL NL6809794A patent/NL6809794A/xx unknown
- 1968-07-13 ES ES356142A patent/ES356142A1/es not_active Expired
- 1968-07-15 IE IE83968A patent/IE32197B1/xx unknown
- 1968-07-16 FR FR1586125D patent/FR1586125A/fr not_active Expired
- 1968-07-16 GB GB33831/68A patent/GB1240545A/en not_active Expired
- 1968-07-16 GB GB4945970A patent/GB1240546A/en not_active Expired
- 1968-07-17 DE DE19681792053 patent/DE1792053B1/de active Pending
- 1968-07-17 BE BE718183D patent/BE718183A/xx not_active IP Right Cessation
- 1968-10-11 FR FR169591A patent/FR8146M/fr not_active Expired
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0291159A3 (en) * | 1987-04-01 | 1993-03-17 | Dak-Laboratoriet A/S | Aminosalicylic-acid derivatives for the treatment of psoriasis |
| WO1992004029A1 (en) * | 1990-08-29 | 1992-03-19 | Donald Leslie Simmons | Composition containing silver sulfadiazine and benzocaine for use in the treatment of wounds following laser surgery |
| EP0480189A1 (en) * | 1990-10-05 | 1992-04-15 | Altergon S.A. | Pharmaceutical compositions for topical use comprising hyaluronic acid sodium salt and disinfectant substances |
| US7074788B2 (en) | 2001-11-22 | 2006-07-11 | Biovitrum Ab | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| WO2004103980A1 (en) * | 2003-05-21 | 2004-12-02 | Biovitrum Ab | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type i |
| US7173030B2 (en) | 2003-05-21 | 2007-02-06 | Biovitrum Ab | Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1 |
| WO2004112784A1 (en) * | 2003-06-25 | 2004-12-29 | Biovitrum Ab | New use i |
| WO2004113310A1 (en) * | 2003-06-25 | 2004-12-29 | Biovitrum Ab | Use of an inhibitor of 11-b-hydroxysteroid dehydrogenase type 1 compounds for promoting wound healing |
| WO2004112783A1 (en) * | 2003-06-25 | 2004-12-29 | Biovitrum Ab | New use iv |
| WO2004112785A1 (en) * | 2003-06-25 | 2004-12-29 | Biovitrum Ab | New use iii |
| WO2004112779A1 (en) * | 2003-06-25 | 2004-12-29 | Biovitrum Ab | New use vii |
| WO2004112782A1 (en) * | 2003-06-25 | 2004-12-29 | Biovitrum Ab | New use v |
Also Published As
| Publication number | Publication date |
|---|---|
| FR1586125A (enrdf_load_stackoverflow) | 1970-02-13 |
| FR8146M (enrdf_load_stackoverflow) | 1970-08-17 |
| PH10639A (en) | 1977-07-22 |
| NL6809794A (enrdf_load_stackoverflow) | 1969-01-21 |
| IE32197L (en) | 1969-01-17 |
| IE32197B1 (en) | 1973-05-16 |
| DE1792053B1 (de) | 1971-07-29 |
| GB1240546A (en) | 1971-07-28 |
| BE718183A (enrdf_load_stackoverflow) | 1969-01-17 |
| ES356142A1 (es) | 1970-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1240545A (en) | Silver-containing therapeutic agents | |
| FI45401C (fi) | Menetelmä valmistaa natriumkloridin ja kaliumkloridin muodostamia, syö täviä suolaseoksia. | |
| GB1388178A (en) | Benzylpyrimidine derivatives | |
| GB1252286A (enrdf_load_stackoverflow) | ||
| GB1361198A (en) | Disulphide compounds and process for their manufa'ture | |
| GB1314899A (en) | Thiosemicarbazones processes for their preparations and compositions incorporating them | |
| GB1199951A (en) | Modified Dextran and Derivatives Thereof | |
| ES368399A1 (es) | Procedimiento para la preparacion de nuevos 1-fenoxi-2-hi- droxi - 3-ter-butilamino propanos sustituidos. | |
| AU452927B2 (en) | Production of anhydrous chloroferrate complexes from ferric chloride inan aqueous system | |
| GB1296161A (enrdf_load_stackoverflow) | ||
| GB1134516A (en) | Antiviral compositions and treatment | |
| GB1175590A (en) | Therapeutic Compositions | |
| GB1388179A (en) | Benzylpyrimidine derivatives | |
| CA767590A (en) | Process for treatment of sodium chloride | |
| GB1053177A (enrdf_load_stackoverflow) | ||
| GB1232780A (enrdf_load_stackoverflow) | ||
| ES276824A1 (es) | Procedimiento para la rectificación de baños salinos fundidos | |
| CA859747A (en) | Metal salt complexes of imidazolylphosphonothioates | |
| CA649784A (en) | Alkali metal salt of carboxymethylcellulose | |
| CA804275A (en) | Cold working of ferrous stock | |
| GB1153649A (en) | Substituted Quinoline-3-Carboxylates | |
| FR2312M (fr) | Nouveau sel potassique de toxicité réduite pour le traitement des hypokaliémies : ascorbate de potassium. | |
| CA754991A (en) | Potassium chloride treatment | |
| AU451256B2 (en) | Ar or ar (alkylthio) benzoyl chloride phenylhydrates and their biological activities | |
| CA811133A (en) | Removal of certain metallic and organic impurities from an aqueous quaternary ammonium salt solution |